MMSL 2016, 85(3):111-120 | DOI: 10.31482/mmsl.2016.020

FECAL MICROBIOTA THERAPY AND ITS POTENTIAL IN MEDICAL PRACTICEReview article

Kateřina Hašková1,2, Markéta Dyrhonová ORCID...2, Vanda Boštíková ORCID...2,3*
1 Department of Infectious Diseases, Hospital Melnik, Melnik, Czech Republic
2 Department of Epidemiology, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic
3 Faculty of Informatics and Management, University of Hradec Kralove, Hradec Kralove, Czech Republic

Fecal microbiota therapy is going through its renaissance period. Even in ancient China, stool and its derivats were used for therapy of various diseases. Now thanks to new molecular methods a new knowledge about the intestinal microbiome and its interference with the human physiology, this method can be used for concrete therapy of disease.

Keywords: fecal microbiota therapy; Clostridium difficile; infection; immunocompromised patients

Received: August 30, 2016; Revised: September 16, 2016; Published: September 27, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hašková, K., Dyrhonová, M., & Boštíková, V. (2016). FECAL MICROBIOTA THERAPY AND ITS POTENTIAL IN MEDICAL PRACTICE. MMSL, 85(3), 111-120. doi: 10.31482/mmsl.2016.020
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kennedy NA, Walker AW, Berry SH, et al. The impact of different DNA extraction kits and laboratories upon the assessment of human gut microbiota composition by 16S rRNA gene sequencing. PLoS One. 2014, 9(2), e88982. Go to original source... Go to PubMed...
    2. Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell. 2012, 148(6), 1258-1270. Go to original source... Go to PubMed...
    3. Lozupone C, Stombaugh J, Gordon J. Diversity, stability and resilience of the human gut microbiota. Nature. 2012. Go to original source...
    4. Tlaskalová-Hogenová H, Stěpánková R, Kozáková H, et al. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol. 2011, 8(2), 110-120. Go to original source... Go to PubMed...
    5. Kootte RS, Vrieze A, Holleman F, et al. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes Obes Metab. 2012, 14(2), 112-120. Go to original source... Go to PubMed...
    6. Pavlova V, Georgieva L, Paunova T. CARBOHYDRATE LOCALIZATION IN INTESTINAL GLYCOCALYX. Medicine (Baltimore). 2013.
    7. Petrof EO, Gloor GB, Vanner SJ, et al. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: "RePOOPulating" the gut. Microbiome. 2013, 1(1), 3. Go to original source... Go to PubMed...
    8. Borody TJ, Campbell J. Fecal microbiota transplantation: techniques, applications, and issues. Gastroenterol Clin North Am. 2012, 41(4), 781-803. Go to original source... Go to PubMed...
    9. Neemann K, Eichele DD, Smith PW, Bociek R, Akhtari M, Freifeld A. Fecal microbiota transplantation for fulminant Clostridium difficile infection in an allogeneic stem cell transplant patient. Transpl Infect Dis. 2012, 14(6), E161-E165. Go to original source... Go to PubMed...
    10. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis. 2011, 53(10), 994-1002. Go to original source... Go to PubMed...
    11. Rohlke F, Stollman N. Fecal microbiota transplantation in relapsing Clostridium difficile infection. Therap Adv Gastroenterol. 2012, 5(6), 403-420. Go to original source... Go to PubMed...
    12. Hamilton MJM, Weingarden ARA, Sadowsky MJ, Khoruts A. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012, 107(5), 761-767. Go to original source... Go to PubMed...
    13. Brandt L. Safety of fecal microbiota transplantation (FMT) in immunocompromised (Ic) patients with Inflammatory Bowel Disease (IBD). Am 2013. Go to original source...
    14. Kahn SA, Vachon A, Rodriquez D, et al. Patient perceptions of fecal microbiota transplantation for ulcerative colitis. Inflamm Bowel Dis. 2013, 19(7), 1506-1513. Go to original source... Go to PubMed...
    15. Kahn SSA, Gorawara-Bhat R, Rubin DT. Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we? Inflamm bowel. 2012, 18(4), 676-684. Go to original source... Go to PubMed...
    16. Zipursky JS, Sidorsky TI, Freedman CA, Sidorsky MN, Kirkland KB. Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection. Clin Infect Dis. 2012, 55(12), 1652-1658. Go to original source... Go to PubMed...
    17. Borody TTJ, Paramsothy S, Agrawal G. Fecal microbiota transplantation: indications, methods, evidence, and future directions. Curr Gastroenterol Rep. 2013, 15(8), 337. Go to original source... Go to PubMed...
    18. Brandt LLJ. American Journal of Gastroenterology Lecture: Intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection. Am J Gastroenterol. 2013, 108(2), 177-185. Go to original source... Go to PubMed...
    19. Kassam Z, Lee CH, Yuan Y, Hunt RHR. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J. 2013, 108(4), 500-508. Go to original source... Go to PubMed...
    20. Hirsch BE, Saraiya N, Poeth K, Schwartz RM, Epstein ME, Honig G. Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection. BMC Infect Dis. 2015, 15(1), 191. Go to original source... Go to PubMed...
    21. Youngster I, Russell GH, Pindar C, Ziv-Baran T, Sauk J, Hohmann EL. Oral, Capsulized, Frozen Fecal Microbiota Transplantation for Relapsing Clostridium difficile Infection. JAMA. 2014, 312(17), 1772-1778.
    22. Smith M, Kassam Z, Edelstein C. OpenBiome remains open to serve the medical community. Nat 2014. Go to original source...
    23. Kelly CCR, Ihunnah C, Fischer M, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol. 2014, 109(7), 1065-1071. Go to original source... Go to PubMed...
    24. Borody TJ, Campbell J. Fecal microbiota transplantation: current status and future directions. Expert Rev Gastroenterol Hepatol. 2011, 5(6), 653-655. Go to original source... Go to PubMed...
    25. Smits LP, Bouter KEC, de Vos WM, Borody TJ, Nieuwdorp M. Therapeutic potential of fecal microbiota transplantation. Gastroenterology. 2013, 145(5), 946-953. Go to original source... Go to PubMed...
    26. Brandt LLJ, Aroniadis OCO, Mellow M, et al. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012, 107(7), 1079-1087. Go to original source... Go to PubMed...
    27. Youngster I, Sauk J, Pindar C, et al. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis. 2014, 58(11), 1515-1522. Go to original source... Go to PubMed...
    28. Taur Y, Pamer E. The intestinal microbiota and susceptibility to infection in immunocompromised patients. Curr Opin Infect Dis. 2013. Go to original source... Go to PubMed...
    29. Matuchansky C. Fecal Microbiota Transplantation: The Case of Immunocompromised Patients. Am J Med. 2015. Go to original source... Go to PubMed...
    30. Rupali P, Mittal C. Fecal Microbiota Transplantation for Clostridium Difficile Infection in Immunocompromised Hosts:" One Easy Strategy, One Giant Success". 2014. Go to original source...
    31. Angelis M De, Piccolo M, Vannini L, et al. Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One. 2013, 8(10), e76993. Go to original source... Go to PubMed...
    32. Bolte E. Characterization of the Human Gut Microbiota Metabolite Profile in Autism Spectrum Disorder. 2015.
    33. de Theije CGM, Wopereis H, Ramadan M, et al. Altered gut microbiota and activity in a murine model of autism spectrum disorders. Brain Behav Immun. 2014, 37, 197-206. Go to original source... Go to PubMed...
    34. Angelis M De, Piccolo M, Vannini L. Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. 2013.
    35. Minamoto Y, Otoni C, Büyükleblebici O. the Presence of Oxidative Stress, Fecal Dysbiosis, and Dysfunction of the Fecal Microbiota in Spontaneous Canine Idiopathic Inflammatory Bowel Disease. Gastroenterology. 2014. Go to original source...
    36. Suchodolski J, Dowd S, Wilke V. 16S rRNA gene pyrosequencing reveals bacterial dysbiosis in the duodenum of dogs with idiopathic inflammatory bowel disease. PLoS One. 2012. Go to original source...
    37. Borody TTJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol. 2012, 9(2), 88-96. Go to original source... Go to PubMed...
    38. Martinez C, Antolin M, Santos J, et al. Unstable composition of the fecal microbiota in ulcerative colitis during clinical remission. Am J Gastroenterol. 2008, 103(3), 643-648. Go to original source... Go to PubMed...
    39. Moayyedi P, Surette M, Wolfe M, et al. 929c A randomized, placebo controlled trial of fecal microbiota therapy in active ulcerative colitis. Gastroenterology. 2014, 146(5), S - 159. Go to original source...
    40. De Leon LM, Watson JB, Kelly CR. Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol. 2013, 11(8), 1036-1038. Go to original source... Go to PubMed...
    41. Damman CJ, Miller SI, Surawicz CM, Zisman TL. The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation? Am J Gastroenterol. 2012, 107(10), 1452-1459. Go to original source... Go to PubMed...
    42. Allegretti JR, Hamilton MJ. Restoring the gut microbiome for the treatment of inflammatory bowel diseases. World J Gastroenterol. 2014, 20(13), 3468-3474. Go to original source... Go to PubMed...
    43. Colman RJ, Rubin DT. Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis. 2014, 8(12), 1569-1581. Go to original source... Go to PubMed...
    44. Dlugosz A, Winckler B, Lundin E. No difference in small bowel microbiota between patients with irritable bowel syndrome and healthy controls. Sci Rep. 2015. Go to original source...
    45. Pinn D, Aroniadis O, Brandt L. Is Fecal Microbiota Transplantation the Answer for Irritable Bowel Syndrome? A Single-Center Experience. Am J. 2014. Go to original source... Go to PubMed...
    46. Nicholson J, Holmes E, Kinross J. Host-gut microbiota metabolic interactions. Science (80-) . 2012. Go to original source...
    47. Angelberger S, Reinisch W, Makristathis A, et al. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol. 2013, 108(10), 1620-1630. Go to original source... Go to PubMed...
    48. Ridaura V, Faith J, Rey F, Cheng J. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science (80-) . 2013. Go to original source...
    49. Musso G, Gambino R, Cassader M. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu Rev Med. 2011. Go to original source... Go to PubMed...
    50. Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012, 489(7415), 242-249. Go to original source... Go to PubMed...

    Return to the content